Institut Català d'Oncologia (ICO Hospitalet)

L'Hospitalet de Llobregat, Barcelona 08908

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Breast Cancer

Studies at this site

• Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype — Stopped early